主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA

Archive

  • Select all
    |
    Perspectives & Review
  • Perspectives & Review
    LI Ji'an, LIN Huimin, CHEN Daijie
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Antibacterial drugs, including synthetic antibacterial drugs(quinolones for example) and secondary metabolites and derivatives produced by microorganisms, are substances with inhibitory and killing effects on pathogenic bacteria and other microorganisms. Due to the poor substrate specificity of biosynthetic enzymes involved in secondary metabolites, a series of derivatives with similar structures will be produced during the fermentation of antibiotics, which is not conducive to the separation and purification of antibiotics, but it creates conditions for the technological innovation of “co-production” of antibiotics. In the project of “Green, High-efficiency Key Technology Innovation and Industrialization of Etimicin and Gentamicin Co-production”, which won the second prize of the National Science and Technology Progress Award in 2019, we first proposed the concept of antibiotics “co-production”. The technological innovation of antibiotics “co-production” is not a by-product recovery in the conventional sense. Indeed, it uses strain breeding and fermentation control technology to balance and improve the synthesis ability of the “co-produced” products. And according to the requirements of the target product, the separation and purification technology is used to carry out “active deployment” to realize the high-efficiency antibacterial preparation process that maximizes economic and environmental benefits. In this paper, the basic ideas and conditions of the process innovation of antibiotics “co-production” are analyzed, and some of the antibiotics that are suitable for “co-production” process are listed. Meanwhile, the practical results of the process innovation of aminoglycoside antibiotics “co-line triple production” are illustrated, which provides some references for the process innovation of antibiotics.
  • Perspectives & Review
    YUAN Chunping, HOU Huimin
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Promoting the use of bioplastics is the only way to solve the environmental pollution caused by plastics. Bioplastic is a general term for bio-based plastics and biodegradable plastics. The 14C measurement is usually used to evaluate the environmental value of bioplastics by determination the biocarbon content of bio-based plastics, and/ or degradation degree of biodegradable plastics converted to carbon dioxides and water under composting conditions is also adopted for the evaluation. This paper mainly introduces the structures and properties of several commercial biodegradable bioplastics such as starch-based bioplastics, polylactic acid, polyhydroxyalkanotes, polybutylene succinate, cellulose acetate and their applications in food and pharmaceutical packaging as well as drug carriers. The future application of bioplastics in pharmaceutical packaging is also prospected.
  • Perspectives & Review
    ZHANG Hui, LUAN Hansen, WANG Jian
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Glaucoma is an irreversible blinding eye disease. Generally, the drug treatment is mainly based on ocular hypotensive agents. However, the traditional eye drops have low bioavailability and poor patient compliance, resulting in unsatisfactory clinical treatment. In recent years, novel drug delivery systems have achieved the purpose of sustained release by prolonging the residence time of the drug in eyes, so as to improve the therapeutic effect of glaucoma medications. In this paper, novel drug delivery systems are divided into two types: non-invasive and invasive types. Noninvasive drug delivery systems include eye drops(such as nanoliposomes, in situ gel and cubosomes), contact lenses and ocular inserts. Invasive drug delivery systems include ocular implants and injectable microparticles. At the same time, advantages and disadvantages of each drug delivery system as well as new technologies applied in ocular drug delivery are introduced and the drug release mechanism is specified. It is expected that this paper can provide some references for the development of new preparations for glaucoma.
  • Paper
  • Paper
    CHENG Weiyan
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    A new synthetic process of venetoclax(1), an inhibitor of B-cell lymphoma-2 gene(Bcl-2), was reported in this paper. Methyl 4-fluorosalicylate(4) was prepared from 2,4-difluorobenzoic acid(2) as the starting material by hydroxylation and methylation, and then 4 was coupled with piperazine to afford methyl 4-(piperazin- 1-yl)salicylate(5). Compound 5 was subjected to the reductive amination and condensation to give methyl 2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]- piperazin-1-yl]benzoate(9), following by hydrolysis and condensation to obtain 1. This synthetic route avoided the expensive intermediate 1-(triisopropylsilyl)-5-hydroxy-7-azaindole(12) and its complicated preparation process reported in literature, and selectively introduced hydroxyl group at the 2-position of 2 to avoid poor selectivity, low yield and difficult purification caused by methyl 2,4-difluorobenzoate(13). And it reduced the preparation cost and simplified the process.
  • Paper
    TONG Hongjuan, LIU Bin, ZHANG Cuiya
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    A new synthetic process of 2-(2-amino-3-methoxyphenyl)chromone(PD98059, 1) was reported in this paper. 2-Hydroxy acetophenone(2) reacted with 3-methoxy-2-nitrobenzoic acid(3) to give 2-acetylphenyl 3-methoxy-2-nitrobenzoate(4). Then the latter was subjected to Baker-Venkataraman rearrangement and intramolecular cyclization to obtain the flavonoid. The nitro group was reduced to amino group in the presence of tin/concentrated hydrochloric acid to afford the target compound 1, with a total yield of 37%(based on 2). This synthetic process was simple to operate, with low cost and easy availability of raw materials.
  • Paper
    CHENG Jiawei, LI Mengna, LIN Yanqin, ZHENG Zhiyao, ZHAO Xueqing
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    A new synthetic process for 2-amino-6-(1-methylpiperidin-4-ylcarbonyl)pyridine(1), the key intermediate of lasmiditan hemisuccinate, was reported in this paper. N-(6-bromopyridin-2-yl)pivalamide(4) was obtained via the coupling reaction of 2,6-dibromopyridine(2) and pivalamide(3). Compound 4 was transformed into the corresponding pyridin-2-yl magnesium chloride by i-PrMgCl, followed by the addition of the N-methoxy- N,1-dimethylpiperidin-4-carboxamide(5) to give N-[6-(1-methylpiperidin-4-carbonyl)pyridin-2-yl]pivalamide(6), and 1 was obtained by the hydrolysis of 6. Since its brief work-up procedure and good total yield of 67%(based on 2), this method would be suitable for the manufacturing.
  • Paper
    YU Liguo, SUN Guangxiang, ZHANG Yunran, ZHU Yijun, WANG Bing
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    In order to control the quality of clozapine, six related substances, namely 8-chloro-5,10-dihydro-11Hdibenzo[ b,e][1,4]diazepin-11-one(related substance A), 11,11'-(piperazin-1,4-diyl)bis(8-chloro-5H-dibenzo[b,e][1,4]- diazepine)(related substance B), 8-chloro-11-(piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine(related substance C), [2-[(2-amino-4-chlorophenyl)amino]phenyl](4-methylpiperazin-1-yl)methanone(related substance D), 8-chloro-11- (4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine-1-oxide(related substance E) and 11-(4-methylpiperazin-1- yl)-5H-dibenzo[b,e][1,4]diazepine(related substance F), were synthesized based on the synthetic process of clozapine. Among them, the synthetic method of related substance F has not been found in literature. The structures of the above related substances were confirmed by ESI-HRMS and 1H NMR.
  • Paper
    LI Lele1, WU Yong, HUANG Zongqing, LU Jianguang, FENG Jun
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Ranibizumab has five pairs of disulfide bonds. Due to the reducing environment of the Escherichia coli(E. coli)cytoplasm, the disulfide bonds cannot be correctly paired to form the inactive inclusion bodies. Moreover, the denaturation and renaturation of inclusion bodies are tedious and inefficient. However, the periplasmic space of E. coli contains disulfide bond oxidoreductase, which can provide a suitable oxidizing environment for the correct pairing and folding of disulfide bonds. Therefore, the disulfide bond of ranibizumab, which guided by signal peptide to periplasmic space, can pair and fold correctly and have good biological activity. In this study, recombinant E. coli with periplasmic soluble expression gene was constructed. On the scale of a five litre fermentor, the key parameters were investigated during the high-density fermentation process, such as isopropyl β-D-thiogalactoside concentration, feed rate, induction temperature and dissolved oxygen. The expression of ranibizumab reached (360±4.24)mg/L, and the purified ranibizumab had good antigen binding activity. This method increased the expression of ranibizumab enormously, and realized its high-efficiency expression in the periplasmic space of E. coli, which could provide a reference for its industrialization.
  • Paper
    SONG Jie, WANG Dongli, ZHANG Zhiyi, LU Weiyue, LIU Min
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Non-viral vectors have the advantages of controllable quality, high carrying capacity and low immunogenicity, but the low transfection efficiency limits their application. In the present study, a new functional group 1,3-dicarbamimidoylisophthal amide(BGG) designed by computer simulation was modified to generation 5(G5) polyamidoamine dendrimer by amido bonds, and the product G5-BGG was used as the carrier for delivery of gene drugs. G5-BGG could condense plasmid DNA into positive complexes. Both qualitative and quantitative transfection experiments in vitro showed that G5-BGG could significantly improve the transfection efficiency of report genes in human gastric adenocarcinoma cells(SGC-7901). Meanwhile, the blank vector G5-BGG possessed good biocompatibility. Besides, tumor necrosis factor-related apoptosis-inducing ligand gene(pTRAIL) loaded gene complex G5-BGG/pTRAIL could induce the apoptosis of SGC-7901 cells and inhibit the growth of SGC-7901 cells. In summary, G5-BGG has the potential application in gastric cancer gene therapy.
  • Paper
    JIA Junwei, FENG Zhong, ZHANG Guimin, YU Shanshan, ZHANG Zhao
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Box-Behnken design-response surface methodology and single factor method were respectively adopted to optimize the parameters of pellet core preparation and coating process for sustained-release layer with particle size distribution, roundness and weight gain as indexes. The results showed that the optimal pellet cores had uniform particle size distribution and good roundness, and the optimal coated pellets also had uniform particle size distribution and stable weight gain. There were no significant differences in the release curves of the obtained pellets in water before and after tableting. The release curves of 3 batches of self-made pellet-based sustained-release coating tablets in various pH media were similar to those of the reference listed drug(RLD, Betaloc ZOK), indicating that the process had good reproducibility. A two-period crossover design was used to investigate the pharmacokinetic behaviors of the self-made preparation and RLD in Beagle dogs under fasting and fed conditions, the in vivo and in vitro correlation(IVIVC) and bioequivalence of the self-made preparation were further evaluated. The results showed that the self-made preparation had good IVIVC under both fasting and fed states, and the product was bioequivalent to the RLD.
  • Paper
    GUAN Yongmei, HU Yusen, LIU Jia, KONG Zhaodi, CHEN Lihua
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    null
  • Paper
    ZHANG Xiaoting, LUO Dandong1LI Qingguo, QIU Zhenwen
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    To improve the physical stability of tadalafil solid dispersions(SDs), the effect of cosolvent on the existing state and dissolution of tadalafil in SDs was investigated. The carrier, polyvinyl caprolactam-polyvinyl acetatepolyethylene glycol graft copolymer(Soluplus), and drug were dissolved in acetone or different mixed solvents consisted of acetone and three cosolvents(water, 0.1% formic acid solution and absolute ethanol), then these systems were spray dried to obtain tadalafil SDs. The dynamic light scattering method was used to analyze the average particle size of Soluplus for evaluating the compatibility between tadalafil and Soluplus in different solvent systems. The prepared SDs were characterized by Fourier-transform infrared spectroscopy, X-ray powder diffraction and differential scanning calorimetry, and their dissolution profiles in 0.1% sodium dodecyl sulfate solution were also investigated. Furtherly, the preliminary stabilities of different SDs stored at (40±2)℃ and (75±5)% of relative humidity for 3 months were tested to evaluate the changes in physical properties of the SDs prepared with different mixed solvent systems. The results showed that the mixed solvents consisted of acetone and water in the ratio of 7∶3 improved the compatibility between tadalafil and Soluplus compared with pure acetone, and the corresponding SDs had a superior dissolution rate and good stability among the prepared SDs.
  • Paper
    HUANG Lujia, BI Fan, WANG Zhenghao, CHAI Xinyi, WU Qiongzhu
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    To meet the requirements of Chinese pharmacopoeia 2015 edition and improve the yields of multi-dose oral solution, the parameter range setting of filling volume was discussed in this paper. In process quality control(IPQC) criteria were designed by mathematical modeling and statistical analysis. The specific approaches were measurement of equipment filling accuracy, interpretation of pharmacopeial standards, mathematical model construction and calculation, IPQC criteria setting and performance qualification. The results indicated that the filling volume of current equipment was in accordance with normal distribution and the setting range of filling volume was 150.9 - 152.0 ml. The IPQC criteria were set as following: sampling 32 bottles every 30 min during production process, recording the number of bottles with filling volume less than 150 ml. If the number was greater than or equal to four, it could be considered an accuracy or precision drop of equipment. Then, measures should be taken such as increasing the setting volume or debugging equipment. Statistical methods were applied to data analysis and quality evaluation in this work, which was not only in line with cGMP, but also of universal significance for determining the key parameters of production.
  • Paper
    CHEN Yu, WANG Liyong, LI Wenting, XU Liping, ZHAO Guiyan
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    null
  • Paper
    DING Bing, LU Honghua, SUN Jianhe, FENG Zhong, ZHANG Guimin
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    null
  • Paper
    LIU Jinyan, ZHOU Ainan, CHENG Zhiguo, GUO Dan, LI Jianqi
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    null
  • Paper
    LIU Qingyuan, LIU Zhiyu, ZHU Bingfeng, LIU Zhijiang, ZHANG Guimin
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    A40926 is the precursor for dalbavancin, and in this report, medium pressure preparative chromatography( MPLC) was adopted to separate and enrich each component and related impurities in A40926 mixture. By optimizing the packing and elution method, the polymer microsphere SKP-10 was selected as the packing, and ethanolwater system as the mobile phase for gradient elution. The results showed that the components A1 and B0 with a purity of >95% were obtained through preparing once, and the impurities RS1 and RS3 with a purity of >95% were obtained through preparing twice. Their structures were confirmed by HPLC-QTOF-MS, which were consistent with the structures described in literature. This method was suitable for purification of the components and related impurities in A40926 mixture, and it could provide support for the quality research of dalbavancin.
  • Pharmaceutical Management & Information
  • Pharmaceutical Management & Information
    LI Shuai, LI Gang, CHEN Guiliang
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    ZHENG Yangyang, DING Jinxi, LI Jiaming, WU Qiuting, LI Wei
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    LIU Pengcheng, WANG Wen, WANG Minjiao, CHI Huihui, REN Jingtian
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    GUO Wen, ZHANG Tianyi, ZHOU Bin
    Abstract ( ) Download PDF ( )   Knowledge map   Save